NCT02780700View on ClinicalTrials.gov

Nintedanib Alone or in Combination With Capecitabine in Refractory Metastatic Colorectal Cancer [LUME-Colon 2]

PHASE2TerminatedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

July 5, 2016

Primary Completion Date

September 9, 2016

Study Completion Date

September 9, 2016

Conditions
Colorectal Neoplasms
Interventions
DRUG

Nintedanib

DRUG

Capecitabine

Trial Locations (1)

46845

Fort Wayne Medical Oncology Hematology, Fort Wayne

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY